0 Yorumlar
0 hisse senetleri
467 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Chemotherapy Drug Market Advances Through Continuous Oncology Treatment Innovations" According to the latest report published by Data Bridge Market Research, the Chemotherapy Drug Market CAGR Value Data Bridge Market Research analyses that the chemotherapy drug market which was USD 47,028.67 million in 2022, would rocket up to USD 97,914.53 million by 2030, and is expected to undergo a CAGR of 9.6% during the forecast period. Chemotherapy Drug Marketing report...0 Yorumlar 0 hisse senetleri 405 Views 0 önizleme
-
MET Inhibitor Drug Market Growth and Oncology Research Trends" MET Inhibitor Drug Market Summary: According to the latest report published by Data Bridge Market Research, the MET Inhibitor Drug Market The global MET Inhibitor Drug market size was valued at USD 1.89 billion in 2025 and is expected to reach USD 5.94 billion by 2033, at a CAGR of 15.40% during the forecast period The market research data...0 Yorumlar 0 hisse senetleri 329 Views 0 önizleme
-
MET Inhibitor Drug Market Growth, Precision Oncology Trends and Forecast" According to the latest report published by Data Bridge Market Research, the MET Inhibitor Drug Market The global MET Inhibitor Drug market size was valued at USD 1.89 billion in 2025 and is expected to reach USD 5.94 billion by 2033, at a CAGR of 15.40% during the forecast period The large scale MET Inhibitor Drug Marketing report studies and evaluates...0 Yorumlar 0 hisse senetleri 107 Views 0 önizleme
-
Oral Targeted Oncology Drug Market: Future Outlook & Forecast 2035" According to the latest report published by Data Bridge Market Research, the Oral Targeted Oncology Drug Market The global oral targeted oncology drug market size was valued at USD 20.73 billion in 2025 and is expected to reach USD 43.47 billion by 2033, at a CAGR of 9.70% during the forecast period The comprehensive Oral Targeted Oncology Drug Market...0 Yorumlar 0 hisse senetleri 108 Views 0 önizleme
-
Precision Oncology Drug Portfolio Market Growth, Personalized Cancer Therapy Trends and Forecast"According to the latest report published by Data Bridge Market Research, the Precision Oncology Drug Portfolio Market CAGR Value Precision Oncology Drug Portfolio Market report, businesses can acquire details about market drivers and market restraints which help them to guess about reducing or growing the production of particular product. It also arranges for top to bottom...0 Yorumlar 0 hisse senetleri 155 Views 0 önizleme
-
Precision Oncology Drug Portfolio Market Growth, Personalized Cancer Therapy Trends and Forecast" According to the latest report published by Data Bridge Market Research, the Precision Oncology Drug Portfolio Market The global precision oncology drug portfolio market size was valued at USD 18.76 billion in 2025 and is expected to reach USD 45.46 billion by 2033, at a CAGR of 11.70% during the forecast period The universal Precision Oncology Drug...0 Yorumlar 0 hisse senetleri 137 Views 0 önizleme
-
Precision Oncology Revolution: Antibody Drug Conjugates (ADCs) Market Trends 2026The landscape of cancer treatment is undergoing a seismic shift. Gone are the days when "scorched earth" chemotherapy was the only viable path for late-stage patients. Today, we are living in the era of the "magic bullet" , a concept first envisioned by Paul Ehrlich over a century ago now realized through the Antibody Drug Conjugates (ADCs) Market. By combining the laser-like precision of...0 Yorumlar 0 hisse senetleri 632 Views 0 önizleme
-
SERD (Selective Estrogen Receptor Degrader) Drug Market Advances with Next-Generation Endocrine Therapies and Oncology ResearchAccording to the latest report published by Data Bridge Market Research, the SERD (Selective Estrogen Receptor Degrader) Drug Market The global SERD (Selective Estrogen Receptor Degrader) drug market size was valued at USD 2.84 billion in 2025 and is expected to reach USD 8.93 billion by 2033, at a CAGR of 15.40% during the forecast period The wide ranging SERD (Selective Estrogen...0 Yorumlar 0 hisse senetleri 89 Views 0 önizleme
-
Driving Growth & Opportunities in the Global Oncology Small Molecule Drugs Market Through 2031The Oncology Small Molecule Drugs Market is witnessing transformative growth as pharmaceutical innovation accelerates to address the global cancer burden. With therapeutics that can penetrate cellular targets, modulate intracellular pathways, and be administered orally, small molecule oncology drugs are becoming essential components of cancer treatment regimens worldwide. The Oncology Small...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology AdoptionAccording to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
High Potency Active Pharmaceutical Ingredients Market to Reach USD 66.38 Billion by 2033, Growing at 9.37% CAGRMarket Overview The global high potency active pharmaceutical ingredients market size was valued at USD 29.64 billion in 2024 and is projected to grow from USD 32.42 billion in 2025 to reach USD 66.38 billion in 2033, growing at a CAGR of 9.37% during the forecast period (2025–2033). The global High Potency Active Pharmaceutical Ingredients market...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme
-
Histone Deacetylase Inhibitors Market Advances with Growing Epigenetic Research and Targeted Oncology TherapiesAccording to the latest report published by Data Bridge Market Research, the Histone Deacetylase Inhibitors Market The Global Histone Deacetylase Inhibitors Market was valued at USD 1.3 billion in 2024 and is expected to reach USD 2.3 billion by 2032, at a CAGR of 7.7% during the forecast period The reliable Histone Deacetylase Inhibitors Market research report includes a...0 Yorumlar 0 hisse senetleri 11 Views 0 önizleme
-
Oncology Drugs Market to Reach USD 503.13 Billion by 2033, Growing at 11.6% CAGRMarket Overview The global oncology drugs market size was valued at USD 193.04 billion in 2024 and is projected to grow from USD 209.57 billion in 2025 to USD 503.13 billion by 2033, exhibiting a CAGR of 11.6% during the forecast period (2025-2033). The global Oncology Drugs market is witnessing swift transformation driven by new consumer behaviors, increased...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
Arama Sonuçları
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek